Supriya Lifescience Limited (SUPRIYA) — Free Cash Flow Generation Index
Supriya Lifescience Limited (SUPRIYA) has a Free Cash Flow Generation Index of 0.24x as of September 2025. Free cash flow of Rs133.16 Million represents 0% of operating cash flow (Rs555.65 Million). Explore SUPRIYA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Supriya Lifescience Limited Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Supriya Lifescience Limited across 8 annual periods. For the full cash flow conversion analysis, see Supriya Lifescience Limited cash conversion from operations.
Annual Free Cash Flow Generation for Supriya Lifescience Limited (2018–2025)
Year-by-year Free Cash Flow Generation Index for Supriya Lifescience Limited. Check total reinvestment intensity of Supriya Lifescience Limited to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | Rs101.89 Million | Rs1.73 Billion | Rs1.62 Billion | ▲ +120.7% |
| 2024 | -0.29x | Rs-323.48 Million | Rs1.13 Billion | Rs1.46 Billion | ▲ +55.2% |
| 2023 | -0.64x | Rs-422.13 Million | Rs661.87 Million | Rs1.08 Billion | ▼ -180.3% |
| 2022 | -0.23x | Rs-111.03 Million | Rs488.01 Million | Rs599.04 Million | ▼ -157.4% |
| 2021 | 0.40x | Rs316.89 Million | Rs799.30 Million | Rs482.41 Million | ▼ -49.7% |
| 2020 | 0.79x | Rs915.37 Million | Rs1.16 Billion | Rs245.25 Million | ▼ -8.0% |
| 2019 | 0.86x | Rs417.27 Million | Rs486.72 Million | Rs69.45 Million | ▲ +19.5% |
| 2018 | 0.72x | Rs125.22 Million | Rs174.52 Million | Rs49.30 Million | — |